"Contagion Live" interviewed Dr. Robert Malone, CEO of Atheric on Repurposing Licensed Drugs for Use Against the Zika Virus (and other emerging infectious diseases)

"Through this novel approach to repurposing drugs, Dr. Malone and his team propose that a “shortened pathway to potential licensure,” can be implemented by identifying already licensed drugs that could be potentially effective against the Zika virus."  

- See more at: